South Rampart Pharma Issued Composition of Matter Patent for Novel Non-Toxic Treatment for Pain
To read the article, click the link above.
A New Pain Treatment Requires Accurate And Reliable Data, South Rampart Pharma on Featured on Clinical Leader piece.
To read the article, click the link above.
Co-founder & CEO, Dr. Hernan Bazan, speaks with Dr. Moira Gunn in NPR’s Tech Nation Radio about the need for pain relief innovation.
Dr. Hernan Bazan, the Co-Founder & CEO of South Rampart [...]
South Rampart Pharma Hopes to Develop Safer Pain Medications
South Rampart Pharma Hopes to Develop Safer Pain Medications To [...]
South Rampart Pharma on Empowered Patient Podcast with Karen Jagoda and Dr. Hernan Bazan.
Developing a Non-Opioid Small Molecule Pain Medicine To Overcome the [...]
South Rampart Pharma Invited to Participate in 2021 NIH Innovation Conference & Life Sciences Summit
NOLABA News - Exciting news for local company South Pharma! They've [...]
LSU HSCNO Spin-Out Awarded $1.9M in STTR Fast Track Funding
LSU HSCNO Spin-Out Awarded $1.9M in STTR Fast Track Funding
NIH Awards $1.9 million STTR Grant to Fast Track New Class of Non-Opioid Pain Relievers
NIH Awards $1.9 million STTR Grant to Fast Track New [...]
Promising New Analgesic Offers Pain Relief Without Liver Toxicity
Promising New Analgesic Offers Pain Relief Without Liver Toxicity
Novel Analgesic for Pain Relief Lacks Liver Toxicity
Novel Analgesic for Pain Relief Lacks Liver Toxicity